Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
F2R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
APBB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGM5-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CPNE6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930655 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHB8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NEURL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACOT11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL23A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AFG3L1P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGC32805 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIPOL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR6A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on